We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-16.43%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$791B
AUM Growth
-$200B
Cap. Flow
-$11.4B
Cap. Flow %
-1.44%
Top 10 Hldgs %
26.42%
Holding
3,063
New
88
Increased
1,490
Reduced
1,207
Closed
101

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$3.46B
2
UNH icon
UnitedHealth
UNH
+$2.79B
3
CRM icon
Salesforce
CRM
+$2.38B
4
SHW icon
Sherwin-Williams
SHW
+$1.41B
5
PM icon
Philip Morris
PM
+$1.34B

Sector Composition

Rank Sector Weight
1 Technology 26.68%
2 Healthcare 19.49%
3 Consumer Discretionary 13.07%
4 Financials 11.17%
5 Communication Services 8.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASHR icon
2951
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.6B
-158,100
Closed -$5.23M
AUDC icon
2952
AudioCodes
AUDC
$257M
-18,466
Closed -$472K
BALY icon
2953
Bally's
BALY
$671M
-7,973
Closed -$245K
BKLN icon
2954
Invesco Senior Loan ETF
BKLN
$6.75B
-12,095,600
Closed -$263M
CARM
2955
DELISTED
Carisma Therapeutics
CARM
-10,725
Closed -$129K
CASH icon
2956
Pathward Financial
CASH
$1.78B
-4,373
Closed -$240K
CLAR icon
2957
Clarus
CLAR
$141M
-9,488
Closed -$216K
CLB icon
2958
Core Laboratories
CLB
$571M
-7,500
Closed -$237K
CLPT icon
2959
ClearPoint Neuro
CLPT
$463M
-10,192
Closed -$106K
CVAC
2960
DELISTED
CureVac
CVAC
-450,642
Closed -$8.84M
DCO icon
2961
Ducommun
DCO
$3.04B
-3,848
Closed -$202K
ELF icon
2962
e.l.f. Beauty
ELF
$5.47B
-30,555
Closed -$789K
ENVB icon
2963
Enveric Biosciences
ENVB
$6.24M
-12
Closed -$35K
FFWM
2964
DELISTED
First Foundation Inc
FFWM
-43,627
Closed -$1.06M
GDS icon
2965
GDS Holdings
GDS
$6.56B
-5,758
Closed -$226K
GSHD icon
2966
Goosehead Insurance
GSHD
$2.33B
-6,385
Closed -$502K
HGTY icon
2967
Hagerty
HGTY
$1.3B
-1,151,575
Closed -$12.4M
HOFT icon
2968
Hooker Furnishings Corp
HOFT
$160M
-11,257
Closed -$213K
HYG icon
2969
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
-288,100
Closed -$23.7M
ICLR icon
2970
Icon
ICLR
$12.9B
-2,460
Closed -$598K
IDT icon
2971
IDT Corp
IDT
$1.63B
-7,320
Closed -$250K
IESC icon
2972
IES Holdings
IESC
$15.3B
-5,252
Closed -$211K
BRSL
2973
Brightstar Lottery PLC
BRSL
$2.08B
-8,936
Closed -$221K
IWV icon
2974
iShares Russell 3000 ETF
IWV
$20.4B
-764
Closed -$200K
JD icon
2975
JD.com
JD
$42.7B
-93,765
Closed -$5.43M

Similar funds

T. Rowe Price Associates's Q2 2022 Portfolio in Review

As of Q2 2022, T. Rowe Price Associates held 3,063 positions worth $791B, down 20% from $992B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

T. Rowe Price Associates's Q2 2022 filing shows 88 new, 1,490 increased, 1,207 reduced and 101 closed positions. Its largest new stake was ESAB: 6,073,363 shares worth $266M. The largest sale was Meta Platforms (Facebook), an estimated $4.44B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2022 buy was ESAB: 6,073,363 shares worth $266M.
  • T. Rowe Price Associates added most to Becton Dickinson in Q2 2022, an estimated $3.46B increase.
  • T. Rowe Price Associates's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $4.44B.
  • T. Rowe Price Associates fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $364M.
  • T. Rowe Price Associates's ten largest holdings make up 26% of its $791B portfolio in Q2 2022.
  • T. Rowe Price Associates opened 88 new positions and closed 101 in Q2 2022.
  • T. Rowe Price Associates's portfolio value fell 20% quarter-over-quarter to $791B.

Based on T. Rowe Price Associates's 13F filing for Q2 2022, filed 15 Aug 2022.